JP2003505413A - Cnsおよび眼疾患におけるアゼチジン化合物 - Google Patents
Cnsおよび眼疾患におけるアゼチジン化合物Info
- Publication number
- JP2003505413A JP2003505413A JP2001511908A JP2001511908A JP2003505413A JP 2003505413 A JP2003505413 A JP 2003505413A JP 2001511908 A JP2001511908 A JP 2001511908A JP 2001511908 A JP2001511908 A JP 2001511908A JP 2003505413 A JP2003505413 A JP 2003505413A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- use according
- trifluoromethyl
- azetidine
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9917384.1A GB9917384D0 (en) | 1999-07-23 | 1999-07-23 | Chemical compounds-III |
GB9917384.1 | 1999-07-23 | ||
PCT/GB2000/002817 WO2001007022A2 (fr) | 1999-07-23 | 2000-07-21 | Composes chimiques iii |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003505413A true JP2003505413A (ja) | 2003-02-12 |
Family
ID=10857862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001511908A Withdrawn JP2003505413A (ja) | 1999-07-23 | 2000-07-21 | Cnsおよび眼疾患におけるアゼチジン化合物 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1196165A2 (fr) |
JP (1) | JP2003505413A (fr) |
AU (1) | AU6006000A (fr) |
GB (1) | GB9917384D0 (fr) |
WO (1) | WO2001007022A2 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012509860A (ja) * | 2008-11-24 | 2012-04-26 | エヌエスエイビー、フィリアル アヴ ノイロサーチ スウェーデン エービー、スヴェーリエ | 皮質のカテコールアミン作動性神経伝達のモジュレーターとして有用な新規な3−フェニル−アゼチジン誘導体 |
JP2017530955A (ja) * | 2014-09-03 | 2017-10-19 | ザ ユニバーシティ オブ バーミンガム | 頭蓋内圧上昇の治療 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB872447A (en) * | 1958-12-23 | 1961-07-12 | Lepetit Spa | 1-carbamyl-3-substituted azetidines |
AU2178099A (en) * | 1998-01-23 | 1999-08-09 | Vernalis Research Limited | Azetidinecarboxamide derivatives for treating cns disorders |
-
1999
- 1999-07-23 GB GBGB9917384.1A patent/GB9917384D0/en not_active Ceased
-
2000
- 2000-07-21 AU AU60060/00A patent/AU6006000A/en not_active Abandoned
- 2000-07-21 JP JP2001511908A patent/JP2003505413A/ja not_active Withdrawn
- 2000-07-21 EP EP00946187A patent/EP1196165A2/fr not_active Withdrawn
- 2000-07-21 WO PCT/GB2000/002817 patent/WO2001007022A2/fr not_active Application Discontinuation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012509860A (ja) * | 2008-11-24 | 2012-04-26 | エヌエスエイビー、フィリアル アヴ ノイロサーチ スウェーデン エービー、スヴェーリエ | 皮質のカテコールアミン作動性神経伝達のモジュレーターとして有用な新規な3−フェニル−アゼチジン誘導体 |
JP2017530955A (ja) * | 2014-09-03 | 2017-10-19 | ザ ユニバーシティ オブ バーミンガム | 頭蓋内圧上昇の治療 |
US10835579B2 (en) | 2014-09-03 | 2020-11-17 | Invex Therapeutics Ltd. | Elevated intracranial pressure treatment |
US11738067B2 (en) | 2014-09-03 | 2023-08-29 | Invex Therapeutics Ltd. | Elevated intracranial pressure treatment |
Also Published As
Publication number | Publication date |
---|---|
WO2001007022A3 (fr) | 2001-06-14 |
EP1196165A2 (fr) | 2002-04-17 |
GB9917384D0 (en) | 1999-09-22 |
AU6006000A (en) | 2001-02-13 |
WO2001007022A2 (fr) | 2001-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7217705B2 (en) | Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease | |
EP1617839B1 (fr) | Utilisation de derives d'azetidinecarboxamide a des fins therapeutiques | |
TWI591058B (zh) | [3-(1-(1h-咪唑-4-基)乙基)-2-甲基苯基]甲醇之酯類前藥 | |
JPH09507216A (ja) | 5−(2−イミダゾリニルアミノ)ベンゾイミダゾール誘導体、それらの製法及びα−2−アドレノセプター作動剤としてのそれらの用途 | |
TW200803839A (en) | Use of a CB1 antagonist for treating side effects and negative symptoms of schizophrenia | |
WO1999020620A1 (fr) | Derive d'isoquinoleine et medicament | |
EA009732B1 (ru) | Диарильные и арилгетероарильные производные мочевины в качестве модуляторов 5-ht-рецептора серотонина, пригодные для профилактики и лечения связанных с ним заболеваний | |
AU2019253831B2 (en) | Compositions and methods for treating neurodegenerative diseases | |
JP2006525299A (ja) | アゼチジンカルボキサミド誘導体及びcb1レセプター媒介障害の治療におけるその使用 | |
KR101471585B1 (ko) | 트라마돌 및 콕시브의 공결정 | |
EP1148881A1 (fr) | UTILISATION DE DERIVES DE PYRIDAZINO [4,5-(b)]-INDOLE-1-ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AUX MALADIES LIEES AU DYSFONCTIONNEMENT DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES | |
WO2002045750A1 (fr) | Medicaments combines | |
JP2003505414A (ja) | Cnaおよび眼疾患におけるアゼチジン化合物 | |
JP2003505413A (ja) | Cnsおよび眼疾患におけるアゼチジン化合物 | |
JP2003505418A (ja) | Cns障害の処置のためのアゼチジンカルボキサミド誘導体 | |
JPH05504146A (ja) | シクロアルキル置換グルタルアミド降圧剤 | |
US6514961B1 (en) | Azetidinecarboxamide derivatives for the treatment of CNS disorders | |
JP4542264B2 (ja) | Cns障害を処置するためのアゼチジンカルボキサミド誘導体 | |
NL2031331B1 (en) | Transmucosal delivery of a short-acting psychedelic compound | |
JP2000511193A (ja) | 高血圧の処置法 | |
JP2003246732A (ja) | 1,2−エタンジオール誘導体またはその塩を含有する神経断裂治療剤 | |
JP2001503022A (ja) | アリールアルカノイルピリダジン誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20071002 |